PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Prescience International

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Prescience to Co-host National Heart, Lung and Blood Institute San Diego Innovation Conference - Event to Feature Company Presentations, Investor Panel, Poster Session and Networking - PrescienceIntl.com
Prescience to Co-host National Heart, Lung and Blood Institute San Diego Innovation Conference

 

NewswireToday - /newswire/ - San Francisco, CA, United States, 2013/06/11 - Event to Feature Company Presentations, Investor Panel, Poster Session and Networking - PrescienceIntl.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Prescience International, a firm dedicated to accelerating the commercialization and global adoption of science and technology, announced today its role as co-host of the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute’s (NHLBI) San Diego Innovation Conference. The Conference, which is designed to bring together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries, will be held today Tuesday, June 11, from 10:30 am. until 5:00 pm. at Janssen Research & Development, 3210 Merryfield Row, San Diego, California 92121.

“We are excited to bring the NHLBI showcase to Janssen Labs and the greater San Diego community,” said Melinda Richter, Founder and CEO of Prescience International and Operations Head of Janssen Labs. “Through this symposium, we hope to not only educate the biotech community about the many ways the NHLBI is actively funding and promoting innovation, but also show how the NHLBI supports companies in their quest to commercialize their products and ultimately deliver transformative healthcare to patients.”

The conference will include six company presentations by the following NHLBI-funded companies: Capricor, Inc., Fallbrook Engineering, KAER Biotherapeutics, Targeson, Inc., Vala Sciences, and Vascular BioSciences.

Including the presenting companies, 14 scientific posters that highlight cutting-edge technologies will be on display throughout the day.

In addition, funding and partnering experts from the Johnson & Johnson Innovation Center, the Life Science Angels, Sanderling Ventures and the Tech Coast Angels will participate in an investor panel discussion on how to obtain funding as a startup.

During the conference, leaders from NHLBI will share information about the NHLBI Office of Translational Alliances and Coordination, changes in the SBIR/STTR program re-authorization, and other funding opportunities and resources. NHLBI staff also will be available to provide advice to applicants and awardees.

“Our first regional innovation conference in Maryland was a successful venture.We were able to showcase small businesses funded by the NHLBI SBIR program, introduce potential funding opportunities to current awardees, and provide information to the regional research and business communities about the NHLBI and its programs. We’re excited to bring this program to San Diego, which has a vibrant biotechnology and medical/scientific research community,” said Jodi Black, Ph.D., Deputy Director, Division of Extramural Research Activities, NHLBI, NIH.

Conference sponsorship is provided by Janssen Labs, a life science innovation center created by Janssen Research & Development to provide emerging healthcare companies with many big company advantages through a “no strings attached” model.

About Prescience International
Prescience (prescienceintl.com) is dedicated to the global adoption of life science, cleantech and other high-growth technologies which generate sustainable economic results and have a positive social impact. Prescience engages with private and public clients to create and operate unique innovation centers, design and deliver world-class educational programs, and provide targeted commercialization support services.

About the National Heart, Lung, and Blood Institute (NHLBI)
Part of the National Institutes of Health, the NHLBI plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics.

About the National Institutes of Health (NIH)
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Prescience International

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Prescience to Co-host National Heart, Lung and Blood Institute San Diego Innovation Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Aurelie Gaudin - PrescienceIntl.com 
415-445-4070 madelaine[.]prescienceintl.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Prescience International securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Prescience International / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)